142 related articles for article (PubMed ID: 12872992)
21. Glypican-3 (GPC3) expression in human placenta: localization to the differentiated syncytiotrophoblast.
Khan S; Blackburn M; Mao DL; Huber R; Schlessinger D; Fant M
Histol Histopathol; 2001 Jan; 16(1):71-8. PubMed ID: 11193214
[TBL] [Abstract][Full Text] [Related]
22. A clinical and molecular study of a patient with Simpson-Golabi-Behmel syndrome.
Okamoto N; Yagi M; Imura K; Wada Y
J Hum Genet; 1999; 44(5):327-9. PubMed ID: 10496077
[TBL] [Abstract][Full Text] [Related]
23. Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy.
Gao W; Kim H; Feng M; Phung Y; Xavier CP; Rubin JS; Ho M
Hepatology; 2014 Aug; 60(2):576-87. PubMed ID: 24492943
[TBL] [Abstract][Full Text] [Related]
24. Altered hematopoiesis in glypican-3-deficient mice results in decreased osteoclast differentiation and a delay in endochondral ossification.
Viviano BL; Silverstein L; Pflederer C; Paine-Saunders S; Mills K; Saunders S
Dev Biol; 2005 Jun; 282(1):152-62. PubMed ID: 15936336
[TBL] [Abstract][Full Text] [Related]
25. Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation.
Liu B; Paranjpe S; Bowen WC; Bell AW; Luo JH; Yu YP; Mars WM; Michalopoulos GK
Am J Pathol; 2009 Aug; 175(2):717-24. PubMed ID: 19574424
[TBL] [Abstract][Full Text] [Related]
26. Hedgehog pathway modulation by glypican 3-conjugated heparan sulfate.
Liu YC; Wierbowski BM; Salic A
J Cell Sci; 2022 Mar; 135(6):. PubMed ID: 35142364
[TBL] [Abstract][Full Text] [Related]
27. Expression of glypican 3 (GPC3) in embryonal tumors.
Saikali Z; Sinnett D
Int J Cancer; 2000 Sep; 89(5):418-22. PubMed ID: 11008203
[TBL] [Abstract][Full Text] [Related]
28. Cellular changes resulting from forced expression of glypican-3 in hepatocellular carcinoma cells.
Kwack MH; Choi BY; Sung YK
Mol Cells; 2006 Apr; 21(2):224-8. PubMed ID: 16682817
[TBL] [Abstract][Full Text] [Related]
29. Gpc3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome.
Pellegrini M; Pilia G; Pantano S; Lucchini F; Uda M; Fumi M; Cao A; Schlessinger D; Forabosco A
Dev Dyn; 1998 Dec; 213(4):431-9. PubMed ID: 9853964
[TBL] [Abstract][Full Text] [Related]
30. glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development.
Paine-Saunders S; Viviano BL; Zupicich J; Skarnes WC; Saunders S
Dev Biol; 2000 Sep; 225(1):179-87. PubMed ID: 10964473
[TBL] [Abstract][Full Text] [Related]
31. Processing by convertases is not required for glypican-3-induced stimulation of hepatocellular carcinoma growth.
Capurro MI; Shi W; Sandal S; Filmus J
J Biol Chem; 2005 Dec; 280(50):41201-6. PubMed ID: 16227623
[TBL] [Abstract][Full Text] [Related]
32. Glypican-3 modulates inhibitory Bmp2-Smad signaling to control renal development in vivo.
Hartwig S; Hu MC; Cella C; Piscione T; Filmus J; Rosenblum ND
Mech Dev; 2005 Jul; 122(7-8):928-38. PubMed ID: 15925496
[TBL] [Abstract][Full Text] [Related]
33. Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice.
Liu B; Bell AW; Paranjpe S; Bowen WC; Khillan JS; Luo JH; Mars WM; Michalopoulos GK
Hepatology; 2010 Sep; 52(3):1060-7. PubMed ID: 20812357
[TBL] [Abstract][Full Text] [Related]
34. GPC6, a novel member of the glypican gene family, encodes a product structurally related to GPC4 and is colocalized with GPC5 on human chromosome 13.
Paine-Saunders S; Viviano BL; Saunders S
Genomics; 1999 May; 57(3):455-8. PubMed ID: 10329016
[TBL] [Abstract][Full Text] [Related]
35. Glypican-3 modulates BMP- and FGF-mediated effects during renal branching morphogenesis.
Grisaru S; Cano-Gauci D; Tee J; Filmus J; Rosenblum ND
Dev Biol; 2001 Mar; 231(1):31-46. PubMed ID: 11180950
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model.
Peters MG; Farías E; Colombo L; Filmus J; Puricelli L; Bal de Kier Joffé E
Breast Cancer Res Treat; 2003 Jul; 80(2):221-32. PubMed ID: 12908826
[TBL] [Abstract][Full Text] [Related]
37. Glypican-3 is involved in cellular protection against mitoxantrone in gastric carcinoma cells.
Wichert A; Stege A; Midorikawa Y; Holm PS; Lage H
Oncogene; 2004 Jan; 23(4):945-55. PubMed ID: 14661052
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3.
Zhu XT; Yuan JH; Zhu TT; Li YY; Cheng XY
FEBS J; 2016 Oct; 283(20):3739-3754. PubMed ID: 27573079
[TBL] [Abstract][Full Text] [Related]
39. The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26.
Davoodi J; Kelly J; Gendron NH; MacKenzie AE
Proteomics; 2007 Jun; 7(13):2300-10. PubMed ID: 17549790
[TBL] [Abstract][Full Text] [Related]
40. Molecular analysis of a novel intragenic deletion in GPC3 in three cousins with Simpson-Golabi-Behmel syndrome.
Schmidt J; Hollstein R; Kaiser FJ; Gillessen-Kaesbach G
Am J Med Genet A; 2017 May; 173(5):1400-1405. PubMed ID: 28371070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
